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Abstract
Bacterial biofilms resist host defenses and antibiotics partly because of their decreased metabolism. Some bacteria use
proinflammatory cytokines, such as interleukin (IL)-1b, as cues to promote biofilm formation and to alter virulence. Although
one potential bacterial IL-1b receptor has been identified, current knowledge of the bacterial IL-1b sensing mechanism is
limited. In chronic biofilm infection, periodontitis, Aggregatibacter actinomycetemcomitans requires tight adherence (tad)-
locus to form biofilms, and tissue destroying active lesions contain more IL-1b than inactive ones. The effect of IL-1b on the
metabolic activity of A. actinomycetemcomitans biofilm was tested using alamarBlue
TM. The binding of IL-1b to A.
actinomycetemcomitans cells was investigated using transmission electron microscopy and flow cytometry. To identify the
proteins which interacted with IL-1b, different protein fractions from A. actinomycetemcomitans were run in native-PAGE
and blotted using biotinylated IL-1b and avidin-HRP, and identified using mass spectroscopy. We show that although IL-1b
slightly increases the biofilm formation of A. actinomycetemcomitans, it reduces the metabolic activity of the biofilm. A
similar reduction was observed with all tad-locus mutants except the secretin mutant, although all tested mutant strains as
well as wild type strains bound IL-1b. Our results suggest that IL-1b might be transported into the A.
actinomycetemcomitans cells, and the trimeric form of intracellular ATP synthase subunit b interacted with IL-1b, possibly
explaining the decreased metabolic activity. Because ATP synthase is highly conserved, it might universally enhance biofilm
resistance to host defense by binding IL-1b during inflammation.
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Introduction
Bacterial biofilms are resistant to host defense factors and
antibiotics because of their protective extracellular matrix and
dormant persister cells [1,2]. However, hiding and hibernating
might not be the only strategies that biofilm cells use to thwart host
defenses. In vitro studies with Staphylococcus aureus suggest that
biofilm-forming bacterial cells may sense and respond to
inflammation of the host by binding proinflammatory cytokines,
thereby leading to enhanced biofilm formation [3] and altered
virulence [4]. S. aureus biofilm cells bind more interleukin (IL)-1b
than the respective planktonic cells [3], and IL-1b increases the
expression levels of virulence-associated adhesion molecules and
decreases the expression levels of leukotoxins of S. aureus [4]. It has
been suggested that bacterial cells might internalize IL-1b to alter
their gene expression pattern [4]. However, little attention has
been focused on investigating the bacterial molecular mechanism
that senses proinflammatory cytokines, especially IL-1b.
Periodontitis is a chronic infection caused by bacterial biofilms.
In addition to causing local tissue destruction, periodontitis also
elevates circulating levels of inflammatory mediators [5–8], which
may contribute to the development of systemic diseases such as
cardiovascular diseases [9]. In periodontal inflammation and tissue
destruction, there is an alternation between active and less active
phases, and the active phase is often associated with an increased
production of IL-1b [10], suggesting pathogen-host crosstalk. The
crosstalk between Actinobacillus pleuropneumoniae cells and host
epithelial cells has been shown to cause an upregulation of
biofilm-associated bacterial genes, including secretin coding rcpA
[11]. A member of the same Pasteurellaceae family, Aggregatibacter
(Actinobacillus) actinomycetemcomitans, is related with aggressive forms
of periodontitis. In vitro A. actinomycetemcomitans forms tight biofilms
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18929using a fimbriae network, and in the rat model of periodontitis, a
genetic locus tad is responsible for fimbriae biogenesis and
adherence [12], making it a significant virulence factor [13].
The tad gene cluster has been identified in various gram-negative
and gram-positive species, including well known human pathogens
such as Bordetella pertussis, Mycobacterium tuberculosis, Pseudomonas
aeruginosa and Vibrio cholerae [12]. The A. actinomycetemcomitans tad
locus codes for 14 different proteins (Flp1-Flp2-TadV-RcpCAB-
TadZABCDEFG), of which 13, excluding the pseudopilin (Flp2),
form the macromolecular machinery for fimbriae biogenesis [14].
Four of these proteins (RcpA, RcpB, RcpC, and TadD) are
located on the outer membrane of A. actinomycetemcomitans [15], of
which RcpA belongs to the protein superfamily of secretins [15].
The function of RcpA is to form a channel through which the Flp1
pili are secreted outside the outer membrane [12,16]. Although
the main function of secretins is to secrete proteins across the outer
membrane of Gram-negative species [17], some of them, such as
PilQ of Neisseria meningitides, have been argued to also have an
opposite role. The N. meningitides PilQ multimer has been proposed
to function as an entrance channel for DNA in naturally
competent cells [18].
Although the bacterial-host interaction has been shown to
upregulate bacterial genes crucial to biofilm formation [11], and
IL-1b changes the virulence gene expression pattern of S. aureus
[4], little is known about the bacterial machinery that senses the
inflammatory milieu of the host. Because IL-1b is produced in the
active phase of periodontitis [10], the aim of this study was to
investigate the effects of IL-1b on the formation and the metabolic
activity of the biofilm of a periodontal pathogen, A. actinomyce-
temcomitans, and identify bacterial proteins that interact with IL-1b.
In addition, the possible role of tad-locus outer membrane proteins
in interactions between IL-1b and A. actinomycetemcomitans was
studied using single gene deletion mutants. The results showed
that IL-1b bound and entered into the A. actinomycetemcomitans cells
and decreased their metabolic activity. Additionally, the tad locus
secretin, RcpA, might have a role in the IL-1b internalization
process. The trimeric form of a conserved intracellular protein,
ATP synthase subunit b, involved in energy production, interacted
with IL-1b. Although the interaction can not be claimed to be
specific for IL-1b, it might explain the decrease in metabolic
activity.
Results
Formation of A. actinomycetemcomitans biofilm in the
presence of human IL-1b
Human recombinant IL-1b (10 ng/ml) increased statistically
significantly (p,0.05; Mann-Whitney U-test) the quantity of
measurable biofilm mass of both tested A. actinomycetemcomitans
strains D7S (serotype a) and SA1151 (serotype c) after 6 h
incubation as compared to the control incubation without IL-1b
(Fig. 1).
Metabolic activity of IL-1b treated A.
actinomycetemcomitans cells
The metabolic activity of biofilm from rough colony A.
actinomycetemcomitans isolate D7S decreased when incubated with
human IL-1b (Fig. 2A). Statistically significant decrease (p,0.05,
T-test) was observed after one hour and it lasted for two hours
(Fig. 2A). The decrease in metabolic activity was transient with
clinical strains SA1398 and SA1151 (data not shown). The
phenomenon seemed to be dependent on the IL-1b/cell ratio.
When lower numbers of cells were used, the drop in metabolic
activity of strains SA1398 and SA1151 was similar as detected with
strain D7S (data not shown).
The metabolic activity of planktonic cells of A. actinomycetemco-
mitans decreased when incubated with human IL-1b when the
genome contained the intact rcpA gene (Fig. 2B). However, when
rcpA was deleted, the D7S strain became unresponsive to IL-1b
(Fig. 2B, red line). All planktonic strains showed a similar curve for
alamarBlue
TM reduction over time in the absence of IL-1b
(Fig. 2C), so the decreased metabolic activity observed in the DrcpA
mutant was not due to defective metabolism.
IL-1b internalization
A. actinomycetemcomitans D7S biofilm bound IL-1b when co-
cultured with organotypic oral mucosa (Fig. 3A). The anti-IL-1b
stained samples of organotypic oral mucosa–A. actinomycetemcomitans
biofilm co-culture showed structures similar to the size and shape
of A. actinomycetemcomitans cells (Fig. 3D and G). In these structures,
dark precipitates were located both out- and inside of the bacterial
cells (Fig. 3G). Similar structures were observed in anti-RcpA
stained samples (3E and H), although the extent of precipitate in
the extracellular space prevented the clear detection of the
structures (Fig. 3H). The isotype control IgG stained samples
showed significantly less intense staining (Fig. 3C) than the anti-IL-
1b stained samples, and the bacterial structures were clearer
defined (3F and I) without any detectable dark precipitates (Fig. 3I).
Binding of biotinylated IL-1b on whole cells and different
protein fractions of A. actinomycetemcomitans
Biotinylated IL-1b bound more efficiently than biotinylated
soybean trypsin inhibitor (control protein) on whole cells of all A.
actinomycetemcomitans strains, whether biofilm forming or planktonic
(p,0.001; Wilcoxon Signed Ranks Test) (Fig. 4A). Because
deletion of any of the proteins did not decrease the binding
significantly (p.0.05; Wilcoxon Signed Ranks Test), none of the
deletion mutant proteins coded by tad-locus genes was responsible
for the specific binding of IL-1b. Only the spontaneous smooth-
colony variant (D7SS) of D7S showed a slight decrease in the
percentage of IL-1b positive cells (Fig. 4A), but this decrease was
not statistically significant. However, the DtadD mutant showed
much more binding than the Dflp1-flp2 mutant (p=0.007; Paired
Figure 1. Effect of IL-1b on the formation of A. actinomycetem-
comitans biofilm. The tested strains D7S (serotype a) and SA1151
(serotype c) were rough-colony forming clinical isolates, which
produced fimbriae. Pre-grown (approximately 18 h) biofilms were
grown with/without IL-1b (10 ng/ml) in RPMI 1640 medium, and the
formation of biofilm was estimated with crystal violet staining after 6 h
incubation. The box-plot represents data from four independent
experiments.
doi:10.1371/journal.pone.0018929.g001
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fimbriae production. In addition, IL-1b bound slightly better on
the DrcpA mutant than on Dflp1-flp2 mutant cells, but the
difference between these mutants was not statistically significant.
All fimbriated biofilm-forming isolates (D7S, SA1398, SA1151)
bound less IL-1b than the Dflp1-flp2 mutant when the percentages
of positively stained cells were compared, although only with strain
SA1398 was the difference statistically significant (p=0.046;
Paired samples T-test) (Fig. 4A). However, although the mean
fluorescence intensity (i.e., the amount of cell-bound biotinylated
IL-1b per individual positively stained cell) was somewhat higher
with biofilm-forming isolates (D7S, SA1398, SA1151) than with
the Dflp1-flp2 mutant (Fig. 4B), only SA1151 showed a statistically
significant difference (p=0.014; Paired samples T-test). Similar
results were also observed with the biotinylated control protein
(Fig. 4B).
To further characterize the binding of IL-1b on A. actinomyce-
temcomitans cells, soluble protein fractions were extracted from the
cells and their IL-1b binding capacity was determined. Of the four
fractions tested, only the intracellular protein fraction, which was
soluble in 10 mM HEPES at pH 7.4, was bound to biotinylated
recombinant IL-1b when detected by blotting after native-PAGE.
Three protein bands interacted with biotinylated IL-1b (Fig. 5A).
A reactive protein band, named 305 according to its traveling
distance in native-PAGE, bound more effectively to IL-1b than
control protein, as it was not detected as a prominent band in the
control membrane (Fig. 5B).
Identification of IL-1b binding protein and
characterization of the binding
Protein band 305 was extracted from the silver stained native-
PAGE gel (Fig. 5C) and identified as ATP synthase subunit b by
LS/ESI-MS/MS analysis. Seven peptides, covering 14% of the
sequence (Fig. 5D), were identified.
The trimeric form of the recombinant ATP synthase subunit b
containing the 8-histidine tag at the C-terminus was needed for
binding to IL-1b (Fig. 6A–C). In contrast, the control protein
bound to the monomer of ATP synthase subunit b (Fig. 6D and E).
According to the ELISA results it seems that ATP synthase subunit
b might generally bind more efficiently than, for example, the N-
terminal domain of RcpA to the tested small proteins (data not
shown). However, IL-1b prefers the trimeric form to other forms
of the ATP synthase subunit b.
Discussion
The aim of this study was to elucidate the mechanisms by which
biofilm forming gram-negative bacteria sense IL-1b. IL-1b may be
used as a growth promoting factor by fresh clinical isolates of
various bacterial species [19–21]. IL-1b changes the gene
expression pattern of S. aureus [4], and IL-1b binding as well as
its effects are more pronounced on biofilm cells than on planktonic
cells of S. aureus [3]. However, any observations about the
molecular mechanism that could underlie these phenomena have
not been reported. Because IL-1b is produced in the active phase
Figure 2. Effect of IL-1b on the metabolic activity of A. actinomycetemcomitans. The tested strains D7S (serotype a) was rough colony forming
isolate, which produced fimbriae. Pre-grown (approximately 18 h) biofilms were grown with human IL-1b (10 ng/ml) or without (control) in RPMI
1640 medium and the metabolic activity was followed with alamarBlue
TM (Panel A). Data is shown as percentage of reduced alamarBlue compared to
control. The spontaneous smooth-colony variant (D7SS) of D7S and its planktonic single-gene deletion mutants rcpA, rcpB, tadD, tadG, and flp1-flp2
were studied (Panel B and C). The pre-grown (18 h) cells were incubated with or without human IL-1b (10 ng/ml) in RPMI 1640 medium, and the
metabolic activity was followed using alamarBlue
TM. The results are shown as percentage of metabolic activities of IL-1b-containing reactions
compared to control cultures (Panel B). The metabolic activities of planktonic control cultures (sterile water was substituted for IL-1b) are presented
as the fluorescence of the reduced form of alamarBlue
TM (Panel C). All results are shown as means 6 SD from three independent experiments. Each
experiment contained duplications of each reaction.
doi:10.1371/journal.pone.0018929.g002
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aggressive forms of this biofilm disease, we selected A. actinomyce-
temcomitans as a model organism to study the IL-1b – bacterium
interaction.
Although enhancing slightly the formation of A. actinomycetemco-
mitans biofilm, IL-1b decreased the metabolic activity of both
biofilm and planktonic cells of A. actinomycetemcomitans. This
decreased activity was dependent on the IL-1b/cell ratio, with a
greater ratio producing a longer lasting effect. The metabolic
activity indicator, alamarBlue
TM, is a redox indicator measuring
continued growth and cell proliferation. Enhanced biofilm
formation of A. actinomycetemcomitans support the earlier finding
that IL-1b increases the formation of S. aureus biofilm [3], but it
conflicts slightly with our finding of decreased metabolic activity. It
would be logic to assume that enhanced formation of biofilm
would be accompanied by increased metabolic activity. Because
IL-1b stimulates S. aureus to express molecules that recognize
adhesive matrix molecules (MSCRAMM) [4] involved in the
Figure 3. Internalization of IL-1b by A. actinomycetemcomitans co-cultured with organotypic oral mucosa. Formalin fixed paraffin sections
of A. actinomycetemcomitans biofilm containing co-cultures were treated with anti-IL-1b (Panel A), anti-N-terminal-RcpA (Panel B), or control IgG
(Panel C) after which the binding antibodies were detected with the NovoLink
TM Polymer Detection System (Novocastra
TM). The sections with the
DAB-label were stained with osmium for electron microscopy. Anti-IL-1b stained samples showed structures of A. actinomycetemcomitans cell shape
and size (Panel D), with dark precipitate in both extra- and intracellular space (Panel G). The anti-RcpA stained positive control showed intense
staining (Panel B) with similar structures (Panel E), although the cell structures are less visible due to the extent of the extracellular precipitate (Panel
H). Control IgG antibody showed less staining (Panel C) revealing similar structures (Panel F) without dark precipitates bound to the cell membranes
(Panel I).
doi:10.1371/journal.pone.0018929.g003
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interaction upregulates the expression of genes needed in biofilm
formation [11], it could be hypothesized that IL-1b might change
the gene expression pattern of A. actinomycetemcomitans towards a
phenotype with a denser biofilm with reduced metabolic activity.
Both of these features might favor the survival of bacteria and
resistance to host defense systems in vivo [22]. As in S. aureus, which
lowered the expression of leukotoxins in the presence of IL-1b [4],
IL-1b might also regulate the expression of A. actinomycetemcomitans
leukotoxin, thus having a broader effect on the virulence of the
species. However, future research is necessary to establish whether
A. actinomycetemcomitans responses similarly. The amount of IL-1b
used in our experiments (10 ng/ml) lies in the same range as the
concentration (up to 80 ng/ml) found in gingival crevicular fluid of
active periodontal lesions [10], indicating that the IL-1b effect
could have some in vivo significance.
Because the specific binding of IL-1b has been reported with
various bacterial species [3,19,21], we studied the binding of IL-1b
on A. actinomycetemcomitans clinical strains both in organotypic oral
mucosa co-culture and with flow cytometry. The D7S strain
biofilm bound strongly IL-1b in the co-culture, and all tested stains
bound more IL-1b than control protein on their surfaces as single
cells. Although the number of positively stained cells was lower in
fimbriae producing rough colony strains than in the non-
fimbriated Dflp1-flp2 mutant, positively stained rough colony
isolates bound more IL-1b per cell than the non-fimbriated control
Figure 4. Binding of IL-1b on A. actinomycetemcomitans cells. The
binding on fixed A. actinomycetemcomitans cells was studied using flow
cytometry. The cells were first treated with biotinylated IL-1b after
which they were stained with avidin-FITC. Panel A presents the
percentage of positively stained cells as detected with flow cytometer.
Panel B shows the mean fluorescence intensity in positively stained
cells. Results are shown as means + SD of three independent
experiments. Statistically significant (Two sample paired T-test)
differences between the test strain and Dflp1-flp2 mutant (flp1-flp2-)
are marked with * and **, indicating p#0.05 and p#0.01, respectively.
Solid line indicates the level obtained with the Dflp1-flp2 mutant.
Biotinylated soybean trypsin inhibitor was used as a negative control
protein.
doi:10.1371/journal.pone.0018929.g004
Figure 5. Binding of IL-1b to intracellular protein fraction of A.
actinomycetemcomitans. The samples were run in native-PAGE, and
the proteins were transferred to nitrocellulose membrane. The reactive
bands were then detected using biotinylated IL-1b and, HRP-linked
streptavidin. Control detection included biotinylated soybean trypsin
inhibitor (sti). Reactive protein band 305 (named according to its
travelling distance in these gels), which was more pronounced in IL-1b
incubated detection than in the control detection, was isolated from
identical gel after silver staining. The isolated protein band 305 was
digested with trypsin before peptide separation and peptide identifi-
cation with LC-MS/MS. Panel A shows the blots treated with either IL-1b
or sti. Panel B shows the intensities of the three reactive bands in IL-1b-
treated membranes compared to sti-treated membranes. Panel C
presents the silver stained native-PAGE gel. Panel D shows the seven
peptides that were identified from protein band 305 (denoted by the
sequences given in bold type). According to the peptide sequence data,
the protein was identified as ATP synthase subunit b (Aggregatibacter
actinomycetemcomitans D11S-1) [42]. The Mascot program combined
with Sprot-Trembl (uniprot) protein sequence database was used to the
protein identification. The gels in Panels A and B contained PageRuler
TM
Plus Prestained Protein Ladder (denoted by ‘‘S’’), and some of the
proteins in the ladder are denoted (a–f).
doi:10.1371/journal.pone.0018929.g005
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actinomycetemcomitans that mediates the self-aggregation and adhe-
sion to a variety of surfaces, it could also bind IL-1b. Thus, the
observed fluorescence in fimbriated clinical strains, or at least part
of it, could originate from IL-1b bound to fimbriae. The finding
that the fimbriated strains bound control protein more efficiently
than the non-fimbriated strains supports the above mentioned
explanation.
It has been hypothesized that extracellular proteases might
digest IL-1b into smaller peptides, which could then be
transported across the cell membrane and mediate their effects
inside the bacterial cell [21]. No clear evidence that this happens
has been shown in previous studies, although a potential transfer
mechanisms of extracellular signal peptides across the outer
membrane of Gram-negative bacteria has recently been reported
[23]. The hypothesis is supported by our EM pictures, which show
Figure 6. IL-1b binding capacity of recombinant ATP synthase subunit b of A. actinomycetemcomitans. Recombinant ATP synthase subunit
b (88 mM) was incubated with or without IL-1b (0.29 mM) for 1 h, after which the samples were run in native-PAGE and immunoblotted with anti-IL-1b
(Panel A), or silver stained (Panel B). Three prominent forms could be observed from recombinant ATP synthase subunit b (Panel B). IL-1b bound to
the trimeric form of recombinant ATP synthase subunit b. IL-1b was not detectable from immunoblotted native-PAGE without pre-incubation with
ATP synthase subunit b (Panel A). However, IL-1b was released from the trimeric form of ATP synthase subunit b under denaturing conditions of SDS-
PAGE (Panel C). The sizes of ATP synthase subunit b and IL-1b were 51 kDa and 17 kDa, respectively. The binding of the biotinylated control protein
soy bean trypsin inhibitor (STI) to ATP synthase subunit b was was estimated similarly (Panel D and E) by using streptavidin-HRP in detection, except
the SDS-page was not run. The control protein bound only to the ATP synthase subunit b monomer.
doi:10.1371/journal.pone.0018929.g006
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double cell membrane of A. actinomycetemcomitans cells that were
exposed to IL-1b in a tissue culture model. Moreover, the
trimeric form of intracellular ATP synthase subunit b which
locates on the cytoplasmic side of the inner membrane, bound to
IL-1b. F-ATP synthase produces a majority of the ATP in
oxidative phosphorylation and consists of a membrane located F0
sector and an intracellular F1 sector, which can be solubilized
from the F0 (for a review, see [24]). The F1 sector contains a
catalytic domain, which consists of three b subunits [24]. Thus,
the finding that the trimeric form of b subunit binds IL-1b is
consistent with the finding that IL-1b decreased the metabolic
activity of A. actinomycetemcomitans cells. Amphibian antimicrobial
peptides containing an a-helical structure inhibit Escherichia coli
ATP synthase by binding to its b subunit, and the degree of
inhibition varies between the different peptides [25]. The short
extended a-helical loop (QGQDMEQQ) of IL-1b might act
similarly once inside the cell. The finding that IL-1b decreased
the metabolic activity only transiently might imply that the b
subunit has quite a low affinity to IL-1b and that the cells
consume the IL-1b quickly. However, in the active phase of
periodontitis, IL-1b is produced by the host cells most likely
during an extended period, which may simultaneously attenuate
the metabolic activity of the A. actinomycetemcomitans biofilm.
Because the crosstalk between A. pleuropneumoniae, a close relative
of A. actinomycetemcomitans, and host epithelial cells has been shown
to cause the upregulation of biofilm-associated bacterial genes,
including secretin coding rcpA, which belongs to the tad- locus [11],
we wanted to investigate if the deletion of some of the components
in this Flp-pili producing machinery would affect the ability of A.
actinomycetemcomitans to respond to IL-1b. Of the tested tad-locus
mutants, only the DrcpA mutant was unresponsive to IL-1b. Only
one bacterial IL-1b receptor has been identified so far, the Caf1A
usher protein of Yersinia pestis [26], which is involved in production
and secretion of the F1 fimbrial capsule subunit [27]. The Y. pestis
capsule resembles the A. actinomycetemcomitans fimbriae network in
appearance [27,28]. In F1 fimbrial capsule subunit production, the
Caf1A usher protein has a similar function to that of RcpA in the
Flp1 fimbriae subunit assembly [12,16,27]. Therefore, the results
obtained from the tad-locus mutant strain investigations led us to
hypothesize that RcpA could be the IL-1b receptor on A.
actinomycetemcomitans.
To identify the possible IL-1b receptor, the binding of IL-1b on
A. actinomycetemcomitans tad-locus mutants was studied using flow
cytometry. All tested A. actinomycetemcomitans tad-locus mutants had
the capacity to bind IL-1b more than control protein. Although
the DrcpA mutant did not respond to IL-1b, it bound biotinylated
IL-1b as much or slightly more than the Dflp1-flp2 mutant, which
does not produce fimbriae but has intact outer membrane Tad
machinery. In addition, the recombinant N-terminal domain of
RcpA did not bind IL-1b, although it has been suggested to form
an Ig-like structure frequently involved in protein-protein and
protein-ligand interactions [29]. Of the mutant strains, DrcpA and
DtadD bound more IL-1b than any other strains. Deletion of a
single gene of the tad-locus outer membrane protein has been
shown to affect the expression levels of other Tad outer membrane
proteins [15]. If rcpA is deleted, the expression of RcpB decreases
moderately and RcpC slightly [15]. Similarly, if tadD is deleted, the
DtadD strain produces only subtle amounts of RcpA and RcpB.
Integration of the protein expression profiles of different tad-locus
mutants [15] and our IL-1b binding data suggests that decreased
expression of RcpA might lead to increased binding of IL-1b.
However, no definite conclusions can be drawn, as the expression
data and binding data originate from different mutant clones.
The in vivo consequence of the IL-1b binding activity, and of the
possible behavioral changes in binding bacterial cells, could mainly
be the suppression of local inflammation. Bacterial IL-1b receptors
might function similarly to host anti-inflammatory receptors, such
as IL-1 decoy receptor (IL-1RII) and single Ig IL-1-related
receptor (SIGIRR) (for a review, see [30]), which prevent IL-1b
from promoting inflammation. The diminished inflammatory
response could therefore protect the bacterial cells. Combined
with the decreased metabolic activity, the protection could be
double-sided by increasing the bacterial resistance to host defense
and by decreasing the inflammatory response aimed at clearing
the microbe. Thus, in the progression of chronic infection, the IL-
1b binding activity could play a role in the more quiescent phases
of disease, or in the phase preceding it. The finding that a
conserved intracellular protein interacted with IL-1b implies that
ATP synthase subunit b might play a common role in bacterial IL-
1b sensing machinery. The next, and probably the most exciting
and demanding step, is to identify the specific IL-1b receptor
among the outer membrane proteins.
Materials and Methods
Bacterial strains and growth conditions
The A. actinomycetemcomitans strains used in this study are
presented in Table 1. The clinical isolate D7S, which was used
as the host strain of the tad-locus single gene mutants, originated
from a 28-year-old African-American female (USA) with gener-
alized aggressive periodontitis [31]. All A. actinomycetemcomitans
strains were revived from stocks preserved in 20% skim milk at
280uC, pre-grown on Tryptic soy agar (TSA) supplemented with
5% defibrinated sheep blood, and incubated in candle jars at 37uC
for 3 days (rough colony strains) or 2 days (smooth-colony strains)
before experiments.
Formation of A. actinomycetemcomitans biofilm in the
presence of human IL-1b
Even suspension of plate grown clinical isolates of A.
actinomycetemcomitans were made according to method by Karched
et al. [32] in Trypticase soy broth (TSB) containing 0.6% (wt/vol)
Table 1. Aggregatibacter actinomycetemcomitans strains used
in this study.
Strain Serotype Colony morphology Reference
D7S a rough [31]
SA1398 b rough [43]
SA1151 c rough [43]
D7SS
a a smooth [31]
D7SDflp1-flp2
b::Spe
c a smooth [44]
D7SDrcpA
d::Spe a smooth [44]
D7SDrcpB
e::Spe a smooth [44]
D7SDtadD
f::Spe a smooth [44]
D7SDtadG
g::Spe a smooth [44]
a: spontaneous non-fimbriated variant of D7S;
b: flp locus coding for Flp pili subunit Flp1 and a pseudogene flp2;
c: spectinomycin resistance cassette;
d: gene coding for outer membrane rough colony protein A;
e: gene coding for outer membrane rough colony protein B;
f: gene coding for outer membrane protein TadD;
g: gene coding for inner membrane protein TadG.
doi:10.1371/journal.pone.0018929.t001
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in standard tissue culture treated 48-well cell culture plates (BD
Falcon
TM #353078, Franklin Lakes, NJ, USA) using TSB-YE/Glc,
so that each well contained approximately 5610
7 CFU of A.
actinomycetemcomitans. The cell culture plates were incubated in
candle jar for 18 h at 37uC. After pre-growth of 18 h in TSB-YE/
Glc, the medium was removed with suction, biofilm was washed
with 1 ml sterile 0.85% NaCl, and 950 ml RPMI-1640 medium
with glutamine (EuroClone, Milano, Italy) was added. Wells were
supplemented with 50 ml recombinant human IL-1b (RELIATech
GmbH, Braunschweig, Germany) to final concentration of
10.0 ng/ml. Sterile water (50 ml) was used as control. Biofilms were
incubated in candle jar for 6 h at 37uC before quantification.
Biofilmgrowthwasquantifiedusingmethoddescribed byKaplan
et al. [33]. Briefly biofilm was stained using crystal violet, washed
seven times with 1 ml water, after which the stain was released with
200 ml of 95% ethanol. Half of the total ethanol volume was
transferred into wells of 96-well microtiter plate and the A620nm was
measured using iEMS microplate reader (Labsystems, Helsinki,
Finland). The measured A620nm was related to the one measured
from control containing 0 ng/ml human IL-1b.
Metabolic activity of IL-1b treated A.
actinomycetemcomitans cells
For biofilm cultivations, even suspensions of plate-grown rough
colony isolates of A. actinomycetemcomitans were made in TSB-YE/Glc
as described above. Suspensions were diluted to 5610
7 CFU/ml, or
in some experiments to 1610
7 or 0.2610
7 CFU/ml, in 48-well
standard tissue culture-treated plates, so that each well contained
approximately 2.5610
7 CFU (0.5 or 0.1610
7 CFU, respectively, in
some experiments). The cell culture plates were incubated in candle
jars for 18 h at 37uC. After pre-growth for 18 h in TSB-YE/Glc, the
medium was removed, the biofilms were washed with 1 ml sterile
0.85% NaCl, and 475 ml of RPMI-1640 medium with glutamine
(Sigma, Steinheim, Germany), but without phenol red. Wells were
supplemented with 25 ml recombinant human IL-1b to a final
concentration of 10 ng/ml. Sterile water was used as a control. The
metabolic activity was measured by adding 50 ml of alamarBlue
TM
(AbDSerotec, Oxford, UK) to each well and measuring the
fluorescence (544 nm excitation, 590 nm emission) of the reduced
form of the dye with an Ascent fluorometer (Thermo Labsystems,
H e l s i n k i ,F i n l a n d )a t0 ,0 . 5 ,1 ,1 . 5 ,2 ,3 ,4 ,a n d5h .B i o f i l m sw e r e
incubated in candle jars at 37uC between the measurements.
For planktonic cultivations, even suspensions of plate-grown
non-fimbriated strains of A. actinomycetemcomitans were made in
TSB-YE/Glc as described above, and diluted to 1610
7 CFU/ml
in 14 ml polypropylene round bottom tubes (BD Falcon
TM
#352006) so that each tube contained approximately
1.0610
8 CFU of A. actinomycetemcomitans. The culture tubes were
incubated in candle jars for 18 h at 37uC. After pre-growth for
18 h in TSB-YE/Glc, a 10-ml sample was taken and plated on
TSA-blood plates to confirm that the culture was not contam-
inated. The cells were washed with 10 ml sterile 0.85% NaCl and
suspended in RPMI-1640 medium with glutamine (Sigma) but
without phenol red to a concentration of 5.0610
7 CFU/ml. An
aliquot of 2.4610
7 CFU was added to each well of 48-well
standard tissue culture-treated plates. Wells were supplemented
with 25 ml recombinant human IL-1b to a final concentration of
10 ng/ml, and the metabolic activity was measured by adding
50 ml of alamarBlue
TM, as described above.
IL-1b internalization
IL-1b internalization was studied using organotypic oral mucosa
[34,35] — A. actinomycetemcomitans biofilm co-culture, which was
immunostained with anti-IL-1b IgG after formalin fixation and
paraffin sectioning. The stained samples were first visualized under
a light microscope, after which positively stained biofilms were
examined under a transmission electron microscope.
Briefly, spontaneously immortalized human gingival fibroblasts
(HGFs) [36] were suspended in collagen solution (Vitrogen,
Cohesion technologies, Palo Alto, CA) mixed with Dulbecco’s
modified Eagle’s medium (DMEM, Life Technologies, Paisley,
UK) with 10% fetal calf serum (FCS), 1% essential amino acids
and antibiotics (100 mg/ml streptomycin and 100 IU/ml penicil-
lin) at a cell density of 3610
5 cells/ml. The cell-collagen
suspension (500 ml) was added to each cell culture insert
(Ø 10 mm, polycarbonate membrane, pore size 3.0 mm, Nunc,
Roskilde, Denmark), placed in the wells of cell culture plates
(Costar, Cambridge, MA) and allowed to solidify at 37uC for two
hours. FAD medium [DMEM containing 5% FCS, 5 mg/ml
insulin (Sigma), 0.4 mg /ml hydrocortisone (Sigma), 5 ng/ml
epidermal growth factor (Sigma) and 100 mg/ml ascorbic acid
(Merck, Darmstadt, Germany)] was added to the insert and in the
wells, and the cell cultures were cultivated for a day. Spontane-
ously immortalized human gingival keratinocytes (HGKs) [37]
were suspended in FAD-medium at a cell density of 3.0610
5/ml,
and 500 ml of the suspension was seeded on the surface of each
collagen-fibroblast gel. Epithelial cells were cultivated one day
before the cultures were lifted to the air-liquid interface onto
stainless steel grids. Cultures were grown for five days before
combining with A. actinomycetemcomitans D7S bacteria biofilms.
Even suspensions of the plate-grown A. actinomycetemcomitans D7S
strain were made in TSB-YE/Glc (containing separately autoclaved
glucose) as previously described. A cell suspension containing 5610
9
cells in 1 ml TSB-YE/Glc was added to sterile hydrophilic
polyethersulfone membranes (5 mm diameter, pore size of 0.2 mm,
SuporH-200, Pall Corporation, Ann Arbor, MI) in the bottom of the
wells of 48-well cell culture plates, and biofilms were grown in a
candle jar at 37uC for 24 hours. Biofilms were briefly washed twice
with 0.85% NaCl solution before 24 hours of incubation in RPMI-
1640medium(Sigma)containing 0.6 g/lL-glutamine.Biofilmswere
co-cultured with organotypic culture model for eight hours.
Formalin-fixed paraffin sections of co-cultures were immuno-
stained with anti-IL-1b using the MonoLink
TM Min Polymer
Detection System kit (Novocastra Laboratories Ltd, Newcastle
Upon Tyne, UK) with a few additional steps. After de-
paraffinization, four-micrometer sections were treated with
0.2 mg/ml proteinase K (15 min, 37uC). The endogenous
peroxidase block and protein block treatments were done before
overnight incubation with rabbit anti-IL-1b antibody (Novus
Biologicals, Littleton, CO, USA), control rabbit IgG whole
molecule (Jackson ImmunoResearch Laboratories, PA, USA), or
control rabbit anti-N-terminal-RcpA antibody (ABCELL, Tam-
pere, Finland) at 4uC. To enhance penetration of the polymer, the
sections were treated with post-primary block before adding
NovoLinkPolymer. Hydrogen peroxide was used as a substrate
and DAB was used as a chromogenic electron donor for the
peroxidase reaction, and the sections were counterstained with
hematoxylin. For transmission electron microscopy, the sections
on slides were fixed with 5% glutaraldehyde in 0.16 M s-collidine
buffer. The sections were further fixed in 2% osmium tetroxide in
water for 2 h to visualize the DAB-precipitate for electron
microscopy, dehydrated and embedded in epoxy resin. The
polymerized blocks were removed by heating and cooling from the
glass slides, ultrathin sections were cut, picked on grids without
further staining [38] and examined with a JEOL JEM-1200EX
transmission electron microscope (Japan Electron Optics Labora-
tory, Tokyo, Japan).
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actinomycetemcomitans cells
The binding of IL-1b on A. actinomycetemcomitans cells was studied
using the FluorokineH kit (R&D Systems, Minneapolis, MN, USA).
Briefly, biofilm-forming clinical isolates of A. actinomycetemcomitans
were harvested from culture plates and suspended in TSB-YE/Glc
to a concentration of 10
8 CFU/ml [32], from which 5610
8 CFU
was taken and cultured in 50 ml tissue culture flasks (Cellstar
#690160, Greiner Bio-One, Frickenhausen, Germany) in candle
jars for 18 h at 37uC. After overnight cultivation, only flasks with a
clear medium were treated as follows. The biofilm was first washed
twice with 10 ml Dulbecco’s PBS (0.9 mM CaCl2,5 0mM MgCl2,
2.7 mM KCl, 1.5 mM KH2P04, 137 mM NaCl 137, 6.5 mM
Na2HPO4). The biofilm was scraped off and suspended [32], and
the cells were fixed with 2.5 ml fixing-solution (1% paraformalde-
hyde, 1% BSA, 0.01% EDTA in Dulbecco’s PBS) for 2 h at 4uC.
They were then filtered through a 100 mm Nylon Cell Strainer (BD
Falcon
TM #2360) to get an even suspension. A total of 1610
8 cells
were aliquotted, centrifuged (8,000 rpm, 5 min), and suspended in
1 ml of sterile Dulbecco’s PBS. Part of this suspension (2.5610
6
cells)wasmixed with either10 ml ofbiotinylatedIL-1b orwith10 ml
of biotinylated control protein (soybean trypsin inhibitor) having a
similar size to IL-1b, and incubated for 1 h at 4uC. After the
incubation with biotinylated protein, 10 ml of avidin-FITC
(FluorokineH kit) was added, and the incubation was continued
for 30 min at 4uC in the dark. The avidin-FITC-labeled cells were
washed twice with 1.5 ml of 16RDF1 buffer (FluorokineH kit) and
finally suspended in 1 ml of the samebuffer.Samples were analyzed
with an Epics XL flow cytometer (Coulter Corporation, Miami,
Fla.). During flow cytometry, bacterial cells were excited at 488 nm
witha 15-mV air-cooled argon ionlaser, and the FITC fluorescence
was detected through a 525-nm band pass filter. Signals were
amplified with the logarithmic mode for side scattering, forward
scattering, and FITC fluorescence. Two parameters, mean
fluorescence intensity (MFI) and percentage of fluorescence-positive
bacterial cells, were determined separately from approximately
5,000 bacteria with a flow rate of 200–300 events/s by gating the
bacterial population according to the forward scatter (FSC)/side
scatter (SSC) bivariate histogram. To exclude disturbing debris in
the FSC/SSC histogram, the discriminant was set to the FSC
channel.
Planktonic mutant strains and the spontaneous smooth colony
variant of D7S (D7SS) were harvested from culture plates and
suspended in TSB-YE/Glc to a concentration of 10
8 CFU/ml,
from which 1.0610
9 CFU was cultured as described above. The
cells were washed once with 10 ml Dulbecco’s PBS, suspended in
2.5 ml fixing-solution, and fixed as described above. The binding
of biotinylated IL-1b was then investigated as described above.
Binding of biotinylated IL-1b on different protein
fractions of A. actinomycetemcomitans cells
The outer membrane fraction, as well as four distinct protein
fractions having different solubilities in the used detergents, were
extracted from whole cells of A. actinomycetemcomitans D7S [39] and
stored at 280uC for further analysis. The total protein
concentrations of A. actinomycetemcomitans cell fractions were
determined using the method of Lowry et al. [40].
The soluble protein fractions were thawed and concentrated
using a Vivaspin 2 concentrator with a MWCO of 3 kDa
(Sartorius, Goettingen, Germany). Soluble protein fractions (25 mg
total protein) were separated by non-denaturing 4–15% tris-HCl
precast gel (Criterion, BIO-RAD, USA) and transferred to
nitrocellulose membranes (ProtranHWhatmanH, Dassel, Germany)
in an Amersham Biosciences Semi-dry blotter. The membrane
was blocked with 5% (w/v) bovine serum albumin (BSA) in PBS
(0.01 M Na2HPO4, 0,15 M NaCl) at pH 7.4 containing 0.1%
Tween-20 (Sigma) (PBS-T) at RT for 60 min. After blocking, the
membrane was washed with PBS-T at RT and then incubated
overnight at 4uC with biotinylated IL-1b (250 ng) (FluorokineH kit)
solution with 0.5% BSA in PBS-T. For the control membrane, a
similar blot was prepared using biotinylated soybean trypsin
inhibitor (FluorokineH kit). The membranes were washed with
PBS-T before incubation with HRP-linked streptavidin (7 mg)
(Sigma) at RT for two hours in 0.5% BSA in PBS-T. The
membranes were washed with PBS-T and detected with ECL
Western blotting substrate (PierceH, Thermo Scientific) and
Biomax Light film (Kodak, Rochester, NY, USA). The outer
membrane protein fraction was not tested, because it was not
possible to run it in native-PAGE.
Identification of IL-1b binding proteins
A non-denaturating 4–15% Tris-HCl precast gel containing
100 mg of total protein was run as described above, and the IL-1b-
binding protein bands were isolated from the gel after silver
staining [41]. The protein band was oxidized with carbamido-
methyl and digested with trypsin before peptide separation with
liquid chromatography (C18-colony) and peptide identification
with ESI-qTOF (QSTAR Pulsar). The Mascot program combined
with the Sprot-Trembl (uniprot) protein sequence database was
used for protein identification. The taxonomy was not predefined
in order to detect all of the contaminating proteins, including the
trypsin used in the digestion.
Cloning, expression and purification of recombinant ATP
synthase subunit b and the N-terminal domain of RcpA,
and investigation of their IL-1b binding capacity
The chemicals used were obtained from Sigma-Aldrich
(Steinheim, Germany) or Merck (Darmstadt, Germany). PCR
primers were obtained from Eurofins MWG Operon (Ebersberg,
Germany), and the pET36b vector was obtained from Novagen
(Darmstadt, Germany). E. coli BL21-CodonPlus(DE3)-RIL cells
and E. coli XLI blue cells were from Stratagene (La Jolla, CA,
USA). The GelJet
TM gel extraction kit, plasmid purification kit,
and PCR product purification kit were obtained from Fermentas
(St. Leon-Rot, Germany).
For cloning procedures, restriction sites (underlined below) were
introduced at the 59end of the respective primers. The forward
primer for the ATP synthase b–coding gene, atpsynb, was 59-
ATACATATGGCGACAGGTAAAATTG-39, and the reverse
primer was 59-ATA CTCGAGCATATTTTTGGCTTTTTCT-
39. For the N-terminal domain (aa: 30–192, excluding the predicted
signal sequence) of RcpA, the used forward primer was 59-ATA-
CATATGCAAAATTTCTCTCTGGATAA-39, and the reverse
primer was 59-ATACTCGAGAATTTGGGTTGTGTC-39.
The genes for atpsynb and rcpA were amplified by PCR using
DNA from A. actinomycetemcomitans strains ATCC 700685
(HK1651) and D7S, respectively. Phusion
TM High-Fidelity DNA
polymerase (Finnzymes, Espoo, Finland) was used in the PCR
amplifications. The products of PCR were cloned into pET36b
using NdeI and XhoI restriction enzymes, T4 Ligase, and CIAP
from Fermentas. The plasmids were transformed into E. coli XL1
blue cells by electroporation. The amplified plasmids were
sequenced in both directions by Eurofins MWG Operon
(Ebersberg, Germany).
The verified plasmid constructs were then transformed into E.
coli BL21-CodonPlus (DE3)-RIL cells. The transformants were
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broth medium (12 g/l tryptone, 24 g/l yeast extract, 0.4%
glycerol, 23.1 g/l KH2PO4 and 125.4 g/l K2HPO4) containing
30 mg/ml kanamycin. The expression of proteins was induced for
3 h using 1 mM IPTG (isopropyl b-D-thiogalactoside). Cells were
first harvested by centrifugation and then ATPsynb-containing
cells (4.2 g) were resuspended in buffer A (50 mM Na-phosphate,
400 mM NaCl, 20 mM imidazole, pH 7.5) containing 1 mM
phenylmethanesulfonylfluoride protease inhibitor and a small
amount of DNAseI (Roche Diagnostics GmbH, Mannheim,
Germany). They were then sonicated 10 times for 10 s. A cell
paste of RcpA protein (4.9 g) was homogenized twice using a
french press (SLM Instruments, Urbana, IL, USA).
After centrifugation (at 17,500 rpm for 30 min), the supernatant
of ATPsynb-containing cells was applied to a Ni
+-charged
HisTrap
TMHP column (Amersham Biosciences), washed with
10% buffer B (50 mM Na-phosphate,400 mM NaCl, 0.5 M
imidazole, pH 7.5), and the recombinant proteins were eluted
with 30% buffer B. Fractions containing the recombinant protein
were pooled and purified further by size-exclusion chromatogra-
phy on a Superdex 200 26/60 column (GE Healthcare)
equilibrated with phosphate buffered saline (PBS) (10 mM
Na2HPO4, 145 mM NaCl, pH 7.2). The fractions containing
ATPsynb were pooled, concentrated and stored at 270uC before
use. For the N-terminal domain of RcpA, the purification was
done similarly, except Hepes buffer (20 mM Hepes, 100 mM
NaCl, pH 7.2) was used in the size-exclusion chromatography.
The purity of both proteins was confirmed by SDS-PAGE and
Coomassie staining.
For detection of the interaction between IL-1b and ATPsynb,
96-well plates (NUNC MaxiSorb, Roskilde, Denmark) were first
coated with either 100 ng of recombinant human IL-1b
(RELIATechGmbH) or soy bean trypsin inhibitor (Sigma) for
three days at 4uC. The dilution was made in PBS containing
sodium azide at 0.05% (PSBN). The same volume of PSBN was
used as a background control. The wells were washed four times
with deionized water. Nonspecific binding sites were blocked by
adding blocking buffer [1% (v/v) bovine serum albumin (BSA)
diluted in PSB containing 0.05% (v/v) Tween-20 and 0.02%
sodium azide (PBS-AT)] and incubating for 2 h at 37uC. After
blocking, wells were washed as described above. A serial dilution
(98 to 3 mM) was done from recombinant His-tagged ATPsynb
and negative control protein RcpA by diluting the proteins in PBS-
AT buffer containing 0.25% BSA. The ELISA procedure for the
detection with HisProbe
TM-HRP (Thermo Scientific, Rockford,
USA) was done according to the manufacturer’s instructions using
ABTS (Sigma) as a peroxidase substrate. ABTS was dissolved to a
1 mM final concentration in 0.01 M sodium citrate buffer at
pH 4.2 containing 0.03% H2O2 (v/v), and the absorbance was
measured at 405 nm (iEMS microplate reader, Labsystems,
Finland).
For further characterization of the interaction, ATP synthase
subunit b (88 mM) and IL-1b (0.29 mM) were incubated in PBS
(10 mM Na2PHO4, 150 mM NaCl, pH 7.5) at RT for one hour.
The samples were run on a native page gel, and half of the gel was
silver-stained as previously described. Immunoblotting was done
to the other side of the gel as a modification of the above-described
protocol. After protein transfer, the membrane was blocked with
PBS-T (0.05% Tween-20) containing 5% (m/v) milk powder.
Overnight incubation was done using 5 mg of rabbit anti-IL-1b
antibody (Novus Biologicals) diluted in PBS-T (0.05% Tween-20)
containing 0.5% (m/v) milk powder. Amersham ECL anti-rabbit
IgG (GE Healthcare) was used in IL-1b detection. The binding
experiment with the biotinylated soy bean trypsin inhibitor was
done similarly, except the detection was made using 1:4000
dilution of streptavidin-HRP (Sigma, S2438) according to the
manufactures instructions.
Statistical analysis
The difference between the binding of biotinylated IL-1b and
the binding of biotinylated control protein on whole bacterial cells
was analyzed using the Wilcoxon Signed Ranks Test. The
differences in the binding of IL-1b on various tad locus deletion
mutants were analyzed using the paired samples T-test. In all
statistical analysis, p-values,0.05 were considered statistically
significant.
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